TechTarget: Tableau adds data storytelling tool in latest update. “Six months after the analytics vendor’s acquisition of Narrative Science comes Data Stories, a new tool aimed at enabling more employees within organizations to work with data.”
9to5Google: Google adding new ‘Insights’ tool for web creators powered by Search Console and Analytics. “Google is rolling out a new Search Console Insights tool that provides creators with an overview of how their content is performing. It’s meant to be an ‘easier way to understand how your content resonates with readers.’”
SC Magazine: Cloudflare announces free, privacy-focused website analytics. “A free website analytics platform unveiled today by Cloudflare will offer services similar to Google and other analytics platform, but without tracking users.”
Social Media Examiner: How to Measure the Success of Your LinkedIn Company Page: 5 Performance Metrics. “Wondering if your LinkedIn company page is delivering the results you hoped for? Do you know where to find the best data to evaluate your efforts? In this article, you’ll learn how to measure five key performance metrics for your LinkedIn company page.”
HathiTrust: HathiTrust Research Center Extends Non-Consumptive Research Tools to Copyrighted Materials: Expanding Research through Fair Use. “Since 2011, HTRC has been developing services and tools to allow researchers to employ text and data mining methodologies using the HathiTrust collection. To date, this service has been available only on the portion of the collection that is out of copyright. With the development of a landmark HathiTrust policy and an updated release of HTRC Analytics, HTRC now provides access to the text of the complete 16.7-million-item HathiTrust corpus for non-consumptive research, such as data mining and computational analysis, including items protected by copyright.” I am probably parading my ignorance here but I didn’t know what “non-consumptive” means. It sounds like research that doesn’t have tuberculosis. HathiTrust has a page to lay it all out.
Instagram analytics site WEBSTA is shutting down. From its About page: “Serving you on your Instagram journey was indeed a great opportunity and an amazing experience. However, due to Instagram’s data usage policy (on April 4th), our service is no longer useful as it used to be to our subscribers, thus we decided to stop our WEBSTA service soon. We have been passionately providing multiple services through WEBSTA since our first launch last January 2011 to help you experience more fun and excitement in your Instagram world and it saddens us to stop our service. However, we would be continually be seeking ways to serve you again in the future.”
TechCrunch: Google’s chatbot analytics platform Chatbase launches to public. “At Google I/O this year, Google quietly introduced a new chatbot analytics platform called Chatbase, a project developed within the company’s internal R&D incubator, Area 120. Today, that platform is being publicly launched to all, after testing with hundreds of early adopters including Ticketmaster, HBO, Keller Williams, Viber, and others.”
Hongkiat: Pull Twitter Analytics From Any Account with Burrrd. “There’s so much you can learn by studying someone’s Twitter account. Who they follow, who follows them, how often they tweet, plus lots of data on the type of content they share. The free web app, Burrrd pulls all this data for you with neat tables & charts for easy browsing. Just enter the Twitter handle of any account and go to town.”
From Yale: Yale team uses Google analytical tool to gauge vaccine effectiveness. “Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published in the Proceedings of the National Academy of Sciences. Pneumococcus, a bacterial pathogen, is one of the most significant causes of pneumonia around the world. According to the Centers for Disease Control and Prevention (CDC), pneumonia is the leading cause of death globally in children under the age of 5. Vaccines that prevent pneumococcal infection can decrease pneumonia rates, but quantifying the impact of the vaccine remains challenging.”
